Molecular Signatures of HPV+ ORL Cancers (OROPAP)
Condition(s):Oropharyngeal Cancer; Human Papillomavirus-Related CarcinomaLast Updated:October 4, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Oropharyngeal Cancer; Human Papillomavirus-Related CarcinomaLast Updated:October 4, 2021Completed
Condition(s):Human Papillomavirus-Related Carcinoma; Oropharyngeal CancerLast Updated:March 7, 2023Recruiting
Condition(s):Oropharynx CancerLast Updated:February 13, 2023Recruiting
Condition(s):Squamous Cell Carcinoma; Oropharynx CancerLast Updated:November 21, 2022Completed
Condition(s):Cancer of the OropharynxLast Updated:March 17, 2023Completed
Condition(s):Human Papillomavirus (HPV)-Positive Oropharyngeal CancerLast Updated:February 6, 2023Recruiting
Condition(s):Locally Advanced HPV Positive Oropharynx CancerLast Updated:April 19, 2023Active, not recruiting
Condition(s):Oropharynx CancerLast Updated:September 10, 2022Active, not recruiting
Condition(s):Oropharynx CancersLast Updated:January 4, 2018Withdrawn
Condition(s):Oropharyngeal CarcinomaLast Updated:November 16, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.